Ultragenyx Pharmaceutical Inc.: Form 8-K, filed Oct 7, 2024
Filed with the SEC on Oct 7, 2024 and accepted by EDGAR at Oct 7, 2024, 08:15 ET.
Items reported
- Item 8.01 Other events
Sections
Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. The main document on sec.gov.
Source: SEC EDGAR, the filing index for accession 0000950170-24-113085. Last ingested by Listed: Oct 30, 2026, 14:15 ET. Listed shows no prices and gives no investment advice.